Balyasny Asset Management LLC Abbott Laboratories Transaction History

Balyasny Asset Management LLC

$57.8 Billion
Q1 2025

A detailed history of Balyasny Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Balyasny Asset Management LLC holds 6,636 shares of ABT stock, worth $886,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,636

Previous 56,200 88.19%

Holding current value

$886,436

Previous $6.36 Million 86.15%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$111.1 - $140.22 $737,259 - $930,499	6,636 New	6,636 $880,000
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $3.66 Million - $4.31 Million	36,527 Added 134.87%	63,610 $7.25 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $1.36 Million - $1.52 Million	-13,504 Reduced 33.27%	27,083 $2.81 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $3.09 Million - $3.41 Million	28,211 Added 227.95%	40,587 $4.61 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $844,088 - $1.03 Million	-9,359 Reduced 43.06%	12,376 $1.36 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $299,008 - $358,760	3,130 Added 16.82%	21,735 $2.11 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $2.44 Million - $2.72 Million	-24,252 Reduced 56.59%	18,605 $2.03 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $77.2 Million - $90.9 Million	-796,934 Reduced 94.9%	42,857 $4.34 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $79.3 Million - $93.1 Million	834,489 Added 15739.14%	839,791 $92.2 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $513,021 - $593,983	5,302 New	5,302 $513,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $28.1 Million - $34.2 Million	-246,268 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $28.5 Million - $34.8 Million	246,268 New	246,268 $34.7 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $52.9 Million - $62.3 Million	-485,583 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $9.08 Million - $9.9 Million	-86,515 Reduced 15.12%	485,583 $53.2 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $23.6 Million - $28.6 Million	-257,426 Reduced 31.03%	572,098 $62.3 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $63.5 Million - $81.3 Million	829,524 New	829,524 $75.8 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $33.9 Million - $39.6 Million	-465,446 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $18.4 Million - $22.2 Million	277,729 Added 147.95%	465,446 $37.2 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $39.3 Million - $44.5 Million	-599,533 Reduced 76.16%	187,717 $13.6 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $47.9 Million - $57.8 Million	787,250 New	787,250 $57.8 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $26.4 Million - $29.1 Million	-457,869 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $103 Million - $117 Million	-1,837,460 Reduced 80.05%	457,869 $27.4 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $2 Million - $2.15 Million	37,334 Added 1.65%	2,295,329 $131 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $109 Million - $121 Million	2,257,995	2,257,995 $120 Million

Others Institutions Holding ABT

# of Institutions

3,541

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $234B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Abbott Laboratories Transaction History